Tong Du

No. 16766, Jingshi Road
Jinan, 250014, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Diabetes mellitus exacerbates myasthenia gravis by upregulating CD40 expression on B cells through the RAGE-HIF-1α-HK2 pathway.

Diabetes mellitus exacerbates myasthenia gravis by upregulating CD40 expression on B cells through the RAGE-HIF-1α-HK2 pathway.

Journal: Journal of neuroimmunology

Published: March 16, 2026

Characteristic MRI pattern in LMNB1-related autosomal dominant leukodystrophy: a case report.

Characteristic MRI pattern in LMNB1-related autosomal dominant leukodystrophy: a case report.

Journal: Frontiers in neuroscience

Published: March 02, 2026

Involvement of monocyte/macrophage NLRP3-IL-1β signaling in the pathogenesis of myasthenia gravis.

Involvement of monocyte/macrophage NLRP3-IL-1β signaling in the pathogenesis of myasthenia gravis.

Journal: International immunopharmacology

Published: December 27, 2025

The value of targeting ketone body metabolism in inflammatory and autoimmune diseases.

The value of targeting ketone body metabolism in inflammatory and autoimmune diseases.

Journal: Journal of translational medicine

Published: November 10, 2025

Methylglyoxal-modification of NLRP3 interrupts NLRP3-NEK7 interaction diminishing inflammasome activation and neuroinflammation.

Methylglyoxal-modification of NLRP3 interrupts NLRP3-NEK7 interaction diminishing inflammasome activation and neuroinflammation.

Journal: Journal of neuroinflammation

Published: September 01, 2025

Diabetes exacerbates myasthenia gravis by enhancing pathological thymic output via the GPR183-7α,25-OHC axis.

Diabetes exacerbates myasthenia gravis by enhancing pathological thymic output via the GPR183-7α,25-OHC axis.

Journal: Journal of neuroinflammation

Published: August 13, 2025

Phenotypic and functional dysregulations of CD8 + T Cells in myasthenia gravis.

Phenotypic and functional dysregulations of CD8 + T Cells in myasthenia gravis.

Journal: Clinical and experimental medicine

Published: January 19, 2025

Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review.

Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review.

Journal: Frontiers in immunology

Published: December 15, 2024

Characteristics of anti-contactin1 antibody positive autoimmune nodopathies combined with membranous nephropathy.

Characteristics of anti-contactin1 antibody positive autoimmune nodopathies combined with membranous nephropathy.

Journal: Journal of neuroimmunology

Published: June 24, 2024

Muscle Weakness in an Adult With 22q11.2 Deletion Syndrome.

Muscle Weakness in an Adult With 22q11.2 Deletion Syndrome.

Journal: CNS neuroscience & therapeutics

Published: January 11, 2024

Myasthenia gravis with tongue muscle atrophy: A case series.

Myasthenia gravis with tongue muscle atrophy: A case series.

Journal: Heliyon

Published: September 28, 2023

Methylglyoxal suppresses microglia inflammatory response through NRF2-IκBζ pathway.

Methylglyoxal suppresses microglia inflammatory response through NRF2-IκBζ pathway.

Journal: Redox biology

Published: July 07, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026